The Aperio Blog
Faye Woolf Talks to PharmaVoice about COVID-19’s Positive Impact on the Clinical Trial Industry
February 2, 2021
Check-out PharmaVoice’s February edition of Commanders & Chiefs to see what Aperio’s Founder and CEO Faye Woolf had to say about getting back to the business of clinical trials and how COVID-19 forced the industry to adapt and adopt some much needed changes.
About Aperio Clinical Outcomes
Aperio Clinical Outcomes provides full, customizable clinical research services across multiple therapeutic areas. Dedicated to transparent interactions with clients, Aperio also offers consulting services in Quality Assurance, Strategic Resourcing, and practical application of the latest Clinical Trial Technology.
In an industry flooded with data, metrics and technology, Aperio remains steadfastly focused on the most important part of the process: people. From start-up to close out and every point in between, Aperio works with its partners to deliver outcomes that will improve patient care and save lives.
Aperio Clinical Outcomes.
We make it clear.